[Longterm effect and maintenance therapy with cutaneous isosorbide dinitrate in patients with coronary heart disease (author's transl)]. 1980

D Brunner, and J Weisbord, and N Meshulam, and S Margulis

The aim of this study was to examine the duration of action of a single cutaneous application of a 10% isosorbide dinitrate ointment (ISDN-S) and also to ascertain the possible appearance of nitrate tolerance after 6--8 months' maintenance therapy with ISDN-S. After a single application of the ointment an effect lasting more than 7 hours was confirmed by bicycle ergometry. After longterm therapy an acute test with rapidly acting sublingual ISDN produced an undiminished response thus showing lack of nitrate tolerance.

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D009824 Ointments Semisolid preparations used topically for protective emollient effects or as a vehicle for local administration of medications. Ointment bases are various mixtures of fats, waxes, animal and plant oils and solid and liquid hydrocarbons. Ointment,Paste,Pastes,Salve,Unguent,Salves,Skin Ointment,Unguents,Ointment, Skin
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004361 Drug Tolerance Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL. Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Brunner, and J Weisbord, and N Meshulam, and S Margulis
September 1980, Deutsche medizinische Wochenschrift (1946),
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
January 1978, Arzneimittel-Forschung,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
August 1977, Zeitschrift fur Kardiologie,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
January 1978, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
August 1979, Revista medica de Chile,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
January 1988, European heart journal,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
October 1975, MMW, Munchener medizinische Wochenschrift,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
November 1976, MMW, Munchener medizinische Wochenschrift,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
June 1982, La Nouvelle presse medicale,
D Brunner, and J Weisbord, and N Meshulam, and S Margulis
October 1979, Revista medica de Chile,
Copied contents to your clipboard!